Exchange Traded Concepts, LLC
- SEC CIK
- 0001457320
- Latest filing
- Aug 11, 2026
ALLO holding history
Allogene Therapeutics, Inc. in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −68,858−100.0% | Sold out | Holders |
| Q1 2025 | 68,858 | $100.5K | <0.1% | +8,183+13.5% | Added | Holders |
| Q4 2024 | 60,675 | $129.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 60,675 | $169.9K | <0.1% | +12,328+25.5% | Added | Holders |
| Q2 2024 | 48,347 | $112.6K | <0.1% | −15,042−23.7% | Reduced | Holders |
| Q1 2024 | 63,389 | $283.3K | <0.1% | +27,349+75.9% | Added | Holders |
| Q4 2023 | 36,040 | $115.7K | <0.1% | +9,139+34.0% | Added | Holders |
| Q3 2023 | 26,901 | $85.3K | <0.1% | +1,964+7.9% | Added | Holders |
| Q2 2023 | 24,937 | $123.9K | <0.1% | +24,937 | New | Holders |